Showing results (121-130 of 239) with videos related to
Sort By:
Pageof 24
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 27, 2020
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disordersElan A Cohen, Howard H Hassman, Larry Ereshefsky, et al.Innovations in Clinical Neuroscience|March 18, 2024
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways ForwardWilliam P Horan, Gary Sachs, Dawn I Velligan, et al.Schizophrenia Bulletin|August 12, 2003
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationaleRichard S E Keefe, Richard C Mohs, Robert M Bilder, et al.Schizophrenia Research. Cognition|July 26, 2017
Disrupted latent inhibition in individuals at ultra high-risk for developing psychosisMichael Kraus, Attilio Rapisarda, Max Lam, et al.Schizophrenia Research|September 15, 2020
Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measuresPhilip D Harvey, William P Horan, Alexandra S Atkins, et al.Molecular Psychiatry|June 17, 2015
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trialsY Iwata, S Nakajima, T Suzuki, et al.Journal of the International Neuropsychological Society : JINS|February 20, 2008
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophreniaS Kristian Hill, John A Sweeney, Robert M Hamer, et al.Schizophrenia Bulletin|March 3, 2010
Report from the working group conference on multisite trial design for cognitive remediation in schizophreniaRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trialRichard S E Keefe, Anil K Malhotra, Herbert Y Meltzer, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Persistent cannabis users show neuropsychological decline from childhood to midlifeMadeline H Meier, Avshalom Caspi, Antony Ambler, et al.Pageof 24